Headlines

Eli Lilly (LLY) to acquire AtaiBeckley (ATAI) to advance therapies for treatment-resistant depression and other mental health conditions; deal value at USD 6.75/shr upfront

Newsquawk Staff ·

Eli Lilly (LLY) to acquire AtaiBeckley (ATAI) to advance therapies for treatment-resistant depression and other mental health conditions; deal value at USD 6.75/shr upfront.

Related headlines